Organic compounds -- part of the class 532-570 series inventions 01/07

20070021597 - Ests and encoded human proteins: The sequences of 5′ ESTs and consensus contigated 5′ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5′ ESTs and consensus contigated 5′ESTs may be to obtain cDNAs and genomic DNAs corresponding to the 5′ ESTs and consensus contigated 5′ESTs. The 5′ ESTs and consensus contigated 5′ESTs may also... Agent: Saliwanchik Lloyd & Saliwanchik A Professional Association

20070021599 - Methods and compositions for detecting cancers: In certain aspects, the invention provides isolated SLC5A8 (also referred to as Hui1) nucleic acid molecules, which encode novel sodium solute symporter members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing SLC5A8 nucleic acid molecules, host cells into which the expression vectors have been introduced, and... Agent: Fish & NeaveIPGroup Ropes & Gray LLP

20070021598 - Mutants of green fluorescent protein: The present invention provides mutants of the Green Fluorescent Protein (GFP) of Aequorea victoria. Specifically provided by the present invention are nucleic acid molecules encoding mutant GFPs, the mutant GFPs encoded by these nucleic acid molecules, vectors and host cells comprising these nucleic acid molecules, and kits comprising one or... Agent: Invitrogen Corporation C/o Intellevate

20070021601 - Nucleic acid amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Hamilton, Brook, Smith & Reynolds, P.C.

20070021600 - Nucleic acid and amino acid sequences relating to enterococcus faecalis for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Enterococcus faecalis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Genome Therapeutics Corporation

20070021602 - High density, miniaturized arrays and methods of manufacturing same: High-density, miniaturized arrays including high surface areas. Arrays described include substrate with a coating of linking agents, as well as arrays with reactants affixed to the substrates. Methods of manufacturing high-density arrays of reactants. The methods include the use of oriented, heat shrink films and elastomeric materials. Methods of functionalizing... Agent: 3m Innovative Properties Company

20070015913 - Mrp3 genes and uses thereof: A nucleic acid capable of driving the expression of a reporter gene in a cancer cell line is disclosed. A polypeptide able to confer multidrug-resistance on a cell is disclosed. Also disclosed are nucleic acids encoding the polypeptide, expression vectors, transformant host cell lines expressing the polypeptide, and antibodies binding... Agent: Fish & Richardson PC

20070015914 - Stereoselective synthesis of beta-nucleosides: n

20070015915 - Method of preparing percarboxy-cyclodextrins by means of regioselective oxidation at position 6 of alpha-, beta-, or gamma- cyclodextrins and applications thereof: Method for the regioselective oxidation of a cyclodextrin, comprising contacting an α-, β-, or γ-cyclodextrin with an oxidation mediator in a stoichiometric quantity.... Agent: Hunton & Williams LLP Intellectual Property Department

20070015916 - Sucralose composition: The present invention provides an improved form of crystalline sucralose.... Agent: Ratnerprestia

20070010664 - Gene expression in the central nervous system regulated by neuroleptic agents: Polynucleotides, polypeptides, kits and methods are provided related to genes expressed in the central nervous system that are regulated by neuroleptics.... Agent: David R Preston & Associates Apc

20070010665 - Nucleic acid and amino acid sequences relating to m. catarrhalis for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Moraxella catarrhalis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Genome Therapeutics Corporation

20070010666 - Hydrocarbon material and method for preparation thereof: The present invention provides a hydrocarbon material with a high ion adsorption ability (specific capacitance) per unit volume of the electrode obtained by heating a starting material mainly composed of polysaccharides, which are easy to obtain and inexpensive. More specifically, the hydrocarbon material can be obtained by heating a polysaccharide-based... Agent: Westerman, Hattori, Daniels & Adrian, LLP

20070004911 - Silylated oligonucleotide compounds: Oligonucleotide comprising at least one internucleotide phosphorus atom protected with a group of formula —XaSiR3R4R5 provided. Xa represent 0 or S, and R3, R4 and R5 each independently are optionally substituted hydrocarbyl groups, selected such that that total number of carbon atoms in R3 plus R4 plus R5 is 4... Agent: Morgan Lewis & Bockius LLP

20070004912 - Novel glyphosate-n-acetyltransferase (gat) genes: Novel proteins are provided herein, including proteins capable of catalyzing the acetylation of glyphosate and other structurally related proteins. Also provided are novel polynucleotides capable of encoding these proteins, compositions that include one or more of these novel proteins and/or polynucleotides, recombinant cells and transgenic plants comprising these novel compounds,... Agent: Pioneer Hi-bred International, Inc.

20070004913 - Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer: A gene (designated 161P2F10B) and its encoded protein are described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in the cancers listed in Table I. Consequently, 161P2F10B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or... Agent: Morrison & Foerster LLP

20070004914 - New immunoeffector compounds: This invention provides compounds containing a 2-deoxy-2-amino-β-D-glucopyranose (glucosamine)glycosidically linked to an cyclic aminoalkyl (aglycon) group. The invention further provides methods for inducing an immune response using the compounds of the present invention in the presence or absence of an antigen. In addition, methods for treating disease with the compounds of... Agent: Townsend And Townsend And Crew, LLP

20070004915 - Process for obtaining hydroxypropylstarch (hps) for use in the treatment of drilling wells: Hydroxypropylstarch (HPS) can be used to treat and maintain drilling wells. HPS decreases filtrate loss in muds of petroleum drilling fluids and is effective at high temperature and pressure. This compound may be obtained by reaction of starch with 1-chloro-2,3-epoxy-propane in approximately eight hours.... Agent: Hunton & Williams LLP Intellectual Property Department